OpGen Inc - Strategy, SWOT and Corporate Finance Report

OpGen Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

OpGen Inc (OpGen) is a molecular diagnostics company that harnesses genomic analysis and bioinformatics to prevent the threat of antibiotic resistance and multi drug resistant organisms (MDROs). The company’s clinical laboratory services include high resolution microbial sequence analysis, swift detection and analysis of antibiotic resistance, and detection of pathogens in blood cultures. OpGen’s develops products that includes QuickFISH, and PNA FISH products, Acuitas products, and Acuitas Lighthouse informatics. OpGen offers its surveillance products and customized screening services to healthcare providers to protect the hospital biome and optimize patient care. The company sells its products in the US and abroad. OpGen is headquartered in Gaithersburg, Maryland, the US.

Scope

  • Detailed information on OpGen Inc required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting OpGen Inc in the form of a SWOT analysis
  • An in-depth view of the business model of OpGen Inc including a breakdown and examination of key business segments
  • News about OpGen Inc, such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

  • Gain understanding of OpGen Inc and the factors that influence its strategies.
  • Track strategic initiatives of the company and latest corporate news and actions.
  • Assess OpGen Inc as a prospective partner, vendor or supplier.
  • Support sales activities by understanding your customers' businesses better.
  • Stay up to date on OpGen Incs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Quest Diagnostics Incorporated - Enterix Colorectal Cancer Screening Test Business

Cepheid

Bio-Reference Laboratories, Inc. - Assets

Bio-Reference Laboratories Inc

Accelerate Diagnostics Inc

Quest Diagnostics Incorporated - Enterix Colorectal Cancer Screening Test Business

Cepheid

Bio-Reference Laboratories, Inc. - Assets

Bio-Reference Laboratories Inc

Accelerate Diagnostics Inc

Table of Contents

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1 - About the Company 6

OpGen Inc - ...

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1 - About the Company 6

OpGen Inc - Key Facts 6

OpGen Inc - Key Employees 7

OpGen Inc - Key Employee Biographies 8

OpGen Inc - Major Products and Services 9

OpGen Inc - History 10

OpGen Inc - Company Statement 11

OpGen Inc - Locations And Subsidiaries 13

Head Office 13

Other Locations & Subsidiaries 13

Section 2 – Company Analysis 14

Company Overview 14

OpGen Inc - Business Description 15

R&D Overview 15

OpGen Inc - Corporate Strategy 16

OpGen Inc - SWOT Analysis 17

SWOT Analysis - Overview 17

OpGen Inc - Strengths 17

OpGen Inc - Weaknesses 18

OpGen Inc - Opportunities 19

OpGen Inc - Threats 20

OpGen Inc - Key Competitors 21

Section 3 – Company Financial Ratios 22

Financial Ratios - Capital Market Ratios 22

Financial Ratios - Annual Ratios 23

Performance Chart 25

Financial Performance 25

Financial Ratios - Interim Ratios 26

Financial Ratios - Ratio Charts 27

Section 4 – Company’s Lifesciences Financial Deals and Alliances 28

OpGen Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 28

OpGen Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018 29

OpGen Inc, Recent Deals Summary 30

Section 5 – Company’s Recent Developments 31

May 08, 2018: OpGen Announces First Quarter 2018 Financial Results 31

Apr 19, 2018: OpGen Completes Rapid Testing Clinical Trial In Colombia And Expands International Operations 33

Mar 15, 2018: OpGen Announces Fourth Quarter and Full Year 2017 Financial Results 34

Mar 13, 2018: OpGen Announces Collaborator in Verification Study for Acuitas Test 36

Feb 13, 2018: OpGen Strengthens Supplier Relationship to Use Industry-Leading Real-Time PCR Technology for New Acuitas Tests 37

Feb 05, 2018: OpGen Regains Compliance With Nasdaq Listing Requirements 38

Feb 01, 2018: OpGen Introduces New RUO Rapid Test for Infection Control and Surveillance Studies 39

Nov 07, 2017: OpGen Reports 2017 Third Quarter Financial Results and Provides Business Update 40

Aug 08, 2017: OpGen Reports 2017 Second Quarter Financial Results and Provides Business Update 42

Jun 15, 2017: OpGen’s Acuitas Detection Technology Utilized in Publication Revealing Prevalence of CRE in Washington D.C. Healthcare Facilities 44

Section 6 – Appendix 45

Methodology 45

Ratio Definitions 45

About GlobalData 49

Contact Us 49

Disclaimer 49

List of Tables

List of Tables

OpGen Inc, Key Facts 6

OpGen Inc, Key Employees 7

OpGen Inc, Key Employee Biographies 8

OpGen Inc, Major Products and Services ...

List of Tables

OpGen Inc, Key Facts 6

OpGen Inc, Key Employees 7

OpGen Inc, Key Employee Biographies 8

OpGen Inc, Major Products and Services 9

OpGen Inc, History 10

OpGen Inc, Subsidiaries 13

OpGen Inc, Key Competitors 21

OpGen Inc, Ratios based on current share price 22

OpGen Inc, Annual Ratios 23

OpGen Inc, Annual Ratios (Cont...1) 24

OpGen Inc, Interim Ratios 26

OpGen Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 28

OpGen Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018 29

OpGen Inc, Recent Deals Summary 30

Currency Codes 45

Capital Market Ratios 45

Equity Ratios 46

Profitability Ratios 46

Cost Ratios 47

Liquidity Ratios 47

Leverage Ratios 48

Efficiency Ratios 48

List of Figures

List of Figures

OpGen Inc, Performance Chart (2013 - 2017) 25

OpGen Inc, Ratio Charts 27

OpGen Inc, Medical Equipment, Deals By Year, 2012 to ...

List of Figures

OpGen Inc, Performance Chart (2013 - 2017) 25

OpGen Inc, Ratio Charts 27

OpGen Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 28

OpGen Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 29

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports